nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivermectin—ABCC1—Mitoxantrone—multiple sclerosis	0.11	0.143	CbGbCtD
Ivermectin—ABCG2—Cladribine—multiple sclerosis	0.101	0.131	CbGbCtD
Ivermectin—ABCG2—Mitoxantrone—multiple sclerosis	0.0739	0.0957	CbGbCtD
Ivermectin—ABCC1—Methotrexate—multiple sclerosis	0.046	0.0596	CbGbCtD
Ivermectin—ABCC2—Dexamethasone—multiple sclerosis	0.0424	0.0549	CbGbCtD
Ivermectin—ABCG2—Dexamethasone—multiple sclerosis	0.0383	0.0496	CbGbCtD
Ivermectin—ABCB1—Methylprednisolone—multiple sclerosis	0.0365	0.0473	CbGbCtD
Ivermectin—ABCC2—Methotrexate—multiple sclerosis	0.0341	0.0441	CbGbCtD
Ivermectin—CYP3A4—Fingolimod—multiple sclerosis	0.034	0.044	CbGbCtD
Ivermectin—ABCG2—Methotrexate—multiple sclerosis	0.0308	0.0399	CbGbCtD
Ivermectin—ABCB1—Mitoxantrone—multiple sclerosis	0.0266	0.0345	CbGbCtD
Ivermectin—ABCB1—Betamethasone—multiple sclerosis	0.0238	0.0307	CbGbCtD
Ivermectin—ABCB1—Prednisolone—multiple sclerosis	0.0234	0.0303	CbGbCtD
Ivermectin—ABCB1—Prednisone—multiple sclerosis	0.0221	0.0286	CbGbCtD
Ivermectin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0219	0.0283	CbGbCtD
Ivermectin—CYP3A4—Triamcinolone—multiple sclerosis	0.0166	0.0215	CbGbCtD
Ivermectin—CYP3A4—Mitoxantrone—multiple sclerosis	0.016	0.0207	CbGbCtD
Ivermectin—CYP3A4—Betamethasone—multiple sclerosis	0.0142	0.0184	CbGbCtD
Ivermectin—CYP3A4—Prednisolone—multiple sclerosis	0.014	0.0182	CbGbCtD
Ivermectin—ABCB1—Dexamethasone—multiple sclerosis	0.0138	0.0179	CbGbCtD
Ivermectin—CYP3A4—Prednisone—multiple sclerosis	0.0133	0.0172	CbGbCtD
Ivermectin—ABCB1—Methotrexate—multiple sclerosis	0.0111	0.0144	CbGbCtD
Ivermectin—CYP3A4—Dexamethasone—multiple sclerosis	0.00828	0.0107	CbGbCtD
Ivermectin—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00281	0.0472	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00281	0.0472	CbGpPWpGaD
Ivermectin—ABCC1—S1P1 pathway—S1PR1—multiple sclerosis	0.00206	0.0345	CbGpPWpGaD
Ivermectin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—S1PR1—multiple sclerosis	0.0019	0.0319	CbGpPWpGaD
Ivermectin—NR1H4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00178	0.03	CbGpPWpGaD
Ivermectin—NR1H4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00178	0.03	CbGpPWpGaD
Ivermectin—NR1H4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.0016	0.0269	CbGpPWpGaD
Ivermectin—NR1H4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00145	0.0243	CbGpPWpGaD
Ivermectin—NR1H4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00145	0.0243	CbGpPWpGaD
Ivermectin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00139	0.0233	CbGpPWpGaD
Ivermectin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00139	0.0233	CbGpPWpGaD
Ivermectin—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.00123	0.0207	CbGpPWpGaD
Ivermectin—ABCC1—Irinotecan Pathway—BCHE—multiple sclerosis	0.00122	0.0204	CbGpPWpGaD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00114	0.0191	CbGpPWpGaD
Ivermectin—ABCG2—Irinotecan Pathway—BCHE—multiple sclerosis	0.00107	0.018	CbGpPWpGaD
Ivermectin—NR1H4—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00105	0.0177	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000952	0.016	CbGpPWpGaD
Ivermectin—ABCG2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000938	0.0157	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00092	0.0154	CbGpPWpGaD
Ivermectin—NR1H4—Endogenous sterols—POMC—multiple sclerosis	0.000865	0.0145	CbGpPWpGaD
Ivermectin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000791	0.0133	CbGpPWpGaD
Ivermectin—NR1H4—Biological oxidations—CYP27B1—multiple sclerosis	0.000769	0.0129	CbGpPWpGaD
Ivermectin—NR1H4—Biological oxidations—CYP24A1—multiple sclerosis	0.000769	0.0129	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000765	0.0128	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—KCNA3—multiple sclerosis	0.000742	0.0125	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000665	0.0112	CbGpPWpGaD
Ivermectin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000653	0.011	CbGpPWpGaD
Ivermectin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000653	0.011	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—LINGO1—multiple sclerosis	0.000593	0.00996	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00058	0.00974	CbGpPWpGaD
Ivermectin—NR1H4—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000551	0.00925	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000545	0.00915	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000458	0.0077	CbGpPWpGaD
Ivermectin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000455	0.00763	CbGpPWpGaD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000452	0.00759	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—KCNA3—multiple sclerosis	0.000437	0.00734	CbGpPWpGaD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000422	0.00709	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000405	0.0068	CbGpPWpGaD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000402	0.00676	CbGpPWpGaD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000402	0.00676	CbGpPWpGaD
Ivermectin—NR1H4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000402	0.00674	CbGpPWpGaD
Ivermectin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000372	0.00625	CbGpPWpGaD
Ivermectin—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000356	0.00598	CbGpPWpGaD
Ivermectin—Pruritus—Cladribine—multiple sclerosis	0.000354	0.00212	CcSEcCtD
Ivermectin—Cough—Mitoxantrone—multiple sclerosis	0.000352	0.0021	CcSEcCtD
Ivermectin—Convulsion—Mitoxantrone—multiple sclerosis	0.000349	0.00209	CcSEcCtD
Ivermectin—Abdominal distension—Prednisone—multiple sclerosis	0.000347	0.00208	CcSEcCtD
Ivermectin—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Ivermectin—Conjunctivitis—Betamethasone—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Ivermectin—Myalgia—Mitoxantrone—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Ivermectin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Ivermectin—Chest pain—Mitoxantrone—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Ivermectin—Diarrhoea—Cladribine—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Ivermectin—Lethargy—Methotrexate—multiple sclerosis	0.00034	0.00203	CcSEcCtD
Ivermectin—Discomfort—Mitoxantrone—multiple sclerosis	0.000339	0.00203	CcSEcCtD
Ivermectin—Sweating increased—Prednisone—multiple sclerosis	0.000336	0.00201	CcSEcCtD
Ivermectin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000336	0.00201	CcSEcCtD
Ivermectin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000333	0.00199	CcSEcCtD
Ivermectin—Confusional state—Mitoxantrone—multiple sclerosis	0.000332	0.00198	CcSEcCtD
Ivermectin—Dizziness—Cladribine—multiple sclerosis	0.000331	0.00198	CcSEcCtD
Ivermectin—Oedema—Mitoxantrone—multiple sclerosis	0.000329	0.00197	CcSEcCtD
Ivermectin—NR1H4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000325	0.00547	CbGpPWpGaD
Ivermectin—Abdominal pain—Azathioprine—multiple sclerosis	0.000322	0.00192	CcSEcCtD
Ivermectin—Body temperature increased—Azathioprine—multiple sclerosis	0.000322	0.00192	CcSEcCtD
Ivermectin—Tachycardia—Mitoxantrone—multiple sclerosis	0.000321	0.00192	CcSEcCtD
Ivermectin—Vomiting—Cladribine—multiple sclerosis	0.000318	0.0019	CcSEcCtD
Ivermectin—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000318	0.0019	CcSEcCtD
Ivermectin—Rash—Cladribine—multiple sclerosis	0.000316	0.00189	CcSEcCtD
Ivermectin—Dermatitis—Cladribine—multiple sclerosis	0.000315	0.00189	CcSEcCtD
Ivermectin—Anorexia—Mitoxantrone—multiple sclerosis	0.000314	0.00187	CcSEcCtD
Ivermectin—Headache—Cladribine—multiple sclerosis	0.000314	0.00187	CcSEcCtD
Ivermectin—Hypotension—Mitoxantrone—multiple sclerosis	0.000308	0.00184	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000302	0.00507	CbGpPWpGaD
Ivermectin—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.0003	0.0018	CcSEcCtD
Ivermectin—Hypersensitivity—Azathioprine—multiple sclerosis	0.0003	0.00179	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.0003	0.00179	CcSEcCtD
Ivermectin—Nausea—Cladribine—multiple sclerosis	0.000297	0.00178	CcSEcCtD
Ivermectin—Vertigo—Prednisolone—multiple sclerosis	0.000297	0.00178	CcSEcCtD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000295	0.00496	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000295	0.00496	CbGpPWpGaD
Ivermectin—Back pain—Triamcinolone—multiple sclerosis	0.000294	0.00176	CcSEcCtD
Ivermectin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000293	0.00175	CcSEcCtD
Ivermectin—Somnolence—Mitoxantrone—multiple sclerosis	0.000293	0.00175	CcSEcCtD
Ivermectin—Asthma—Methotrexate—multiple sclerosis	0.000288	0.00172	CcSEcCtD
Ivermectin—Convulsion—Prednisolone—multiple sclerosis	0.000287	0.00171	CcSEcCtD
Ivermectin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000286	0.00171	CcSEcCtD
Ivermectin—Eosinophilia—Methotrexate—multiple sclerosis	0.000286	0.00171	CcSEcCtD
Ivermectin—Fatigue—Mitoxantrone—multiple sclerosis	0.000284	0.0017	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000283	0.00475	CbGpPWpGaD
Ivermectin—Pain—Mitoxantrone—multiple sclerosis	0.000281	0.00168	CcSEcCtD
Ivermectin—Constipation—Mitoxantrone—multiple sclerosis	0.000281	0.00168	CcSEcCtD
Ivermectin—Diarrhoea—Azathioprine—multiple sclerosis	0.000279	0.00166	CcSEcCtD
Ivermectin—Discomfort—Prednisolone—multiple sclerosis	0.000278	0.00166	CcSEcCtD
Ivermectin—ABCC1—S1P1 pathway—MAPK1—multiple sclerosis	0.000278	0.00467	CbGpPWpGaD
Ivermectin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000276	0.00165	CcSEcCtD
Ivermectin—Vertigo—Triamcinolone—multiple sclerosis	0.000273	0.00163	CcSEcCtD
Ivermectin—Vertigo—Methylprednisolone—multiple sclerosis	0.000273	0.00163	CcSEcCtD
Ivermectin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000271	0.00162	CcSEcCtD
Ivermectin—Oedema—Prednisolone—multiple sclerosis	0.00027	0.00161	CcSEcCtD
Ivermectin—Dizziness—Azathioprine—multiple sclerosis	0.000269	0.00161	CcSEcCtD
Ivermectin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000269	0.00161	CcSEcCtD
Ivermectin—Cough—Triamcinolone—multiple sclerosis	0.000266	0.00159	CcSEcCtD
Ivermectin—Convulsion—Triamcinolone—multiple sclerosis	0.000264	0.00158	CcSEcCtD
Ivermectin—Tachycardia—Prednisolone—multiple sclerosis	0.000264	0.00157	CcSEcCtD
Ivermectin—Convulsion—Methylprednisolone—multiple sclerosis	0.000263	0.00157	CcSEcCtD
Ivermectin—NR1H4—Gene Expression—ZNF746—multiple sclerosis	0.000262	0.00441	CbGpPWpGaD
Ivermectin—Urticaria—Mitoxantrone—multiple sclerosis	0.000261	0.00156	CcSEcCtD
Ivermectin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000261	0.00156	CcSEcCtD
Ivermectin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00026	0.00155	CcSEcCtD
Ivermectin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00026	0.00155	CcSEcCtD
Ivermectin—Myalgia—Triamcinolone—multiple sclerosis	0.000259	0.00155	CcSEcCtD
Ivermectin—Vomiting—Azathioprine—multiple sclerosis	0.000259	0.00155	CcSEcCtD
Ivermectin—Myalgia—Methylprednisolone—multiple sclerosis	0.000258	0.00154	CcSEcCtD
Ivermectin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000258	0.00154	CcSEcCtD
Ivermectin—Rash—Azathioprine—multiple sclerosis	0.000257	0.00153	CcSEcCtD
Ivermectin—Dermatitis—Azathioprine—multiple sclerosis	0.000256	0.00153	CcSEcCtD
Ivermectin—Discomfort—Triamcinolone—multiple sclerosis	0.000256	0.00153	CcSEcCtD
Ivermectin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000255	0.00429	CbGpPWpGaD
Ivermectin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000255	0.00429	CbGpPWpGaD
Ivermectin—Discomfort—Methylprednisolone—multiple sclerosis	0.000255	0.00153	CcSEcCtD
Ivermectin—Headache—Azathioprine—multiple sclerosis	0.000255	0.00152	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000255	0.00152	CcSEcCtD
Ivermectin—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000252	0.00423	CbGpPWpGaD
Ivermectin—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000252	0.00423	CbGpPWpGaD
Ivermectin—Conjunctivitis—Methotrexate—multiple sclerosis	0.00025	0.00149	CcSEcCtD
Ivermectin—Confusional state—Methylprednisolone—multiple sclerosis	0.00025	0.00149	CcSEcCtD
Ivermectin—Oedema—Triamcinolone—multiple sclerosis	0.000248	0.00148	CcSEcCtD
Ivermectin—Vertigo—Betamethasone—multiple sclerosis	0.000248	0.00148	CcSEcCtD
Ivermectin—Vertigo—Dexamethasone—multiple sclerosis	0.000248	0.00148	CcSEcCtD
Ivermectin—Haematuria—Methotrexate—multiple sclerosis	0.000245	0.00147	CcSEcCtD
Ivermectin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000243	0.00145	CcSEcCtD
Ivermectin—Tachycardia—Triamcinolone—multiple sclerosis	0.000242	0.00145	CcSEcCtD
Ivermectin—Nausea—Azathioprine—multiple sclerosis	0.000242	0.00145	CcSEcCtD
Ivermectin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000242	0.00145	CcSEcCtD
Ivermectin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00024	0.00143	CcSEcCtD
Ivermectin—NR1H4—Gene Expression—PTBP1—multiple sclerosis	0.00024	0.00403	CbGpPWpGaD
Ivermectin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00024	0.00143	CcSEcCtD
Ivermectin—Convulsion—Dexamethasone—multiple sclerosis	0.000239	0.00143	CcSEcCtD
Ivermectin—Convulsion—Betamethasone—multiple sclerosis	0.000239	0.00143	CcSEcCtD
Ivermectin—Asthenia—Mitoxantrone—multiple sclerosis	0.000236	0.00141	CcSEcCtD
Ivermectin—Myalgia—Betamethasone—multiple sclerosis	0.000235	0.0014	CcSEcCtD
Ivermectin—Myalgia—Dexamethasone—multiple sclerosis	0.000235	0.0014	CcSEcCtD
Ivermectin—Discomfort—Dexamethasone—multiple sclerosis	0.000232	0.00139	CcSEcCtD
Ivermectin—Discomfort—Betamethasone—multiple sclerosis	0.000232	0.00139	CcSEcCtD
Ivermectin—Hypotension—Methylprednisolone—multiple sclerosis	0.000232	0.00138	CcSEcCtD
Ivermectin—Pain—Prednisolone—multiple sclerosis	0.000231	0.00138	CcSEcCtD
Ivermectin—Hepatitis—Methotrexate—multiple sclerosis	0.000231	0.00138	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000231	0.00387	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000231	0.00387	CbGpPWpGaD
Ivermectin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000229	0.00385	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000229	0.00384	CbGpPWpGaD
Ivermectin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000226	0.00135	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000226	0.00135	CcSEcCtD
Ivermectin—Oedema—Betamethasone—multiple sclerosis	0.000225	0.00135	CcSEcCtD
Ivermectin—Oedema—Dexamethasone—multiple sclerosis	0.000225	0.00135	CcSEcCtD
Ivermectin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000225	0.00135	CcSEcCtD
Ivermectin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000223	0.00133	CcSEcCtD
Ivermectin—Anaemia—Prednisone—multiple sclerosis	0.000222	0.00133	CcSEcCtD
Ivermectin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000221	0.00132	CcSEcCtD
Ivermectin—Tachycardia—Betamethasone—multiple sclerosis	0.00022	0.00131	CcSEcCtD
Ivermectin—Tachycardia—Dexamethasone—multiple sclerosis	0.00022	0.00131	CcSEcCtD
Ivermectin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000218	0.0013	CcSEcCtD
Ivermectin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000218	0.0013	CcSEcCtD
Ivermectin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000218	0.0013	CcSEcCtD
Ivermectin—Vertigo—Prednisone—multiple sclerosis	0.000216	0.00129	CcSEcCtD
Ivermectin—Anorexia—Dexamethasone—multiple sclerosis	0.000215	0.00128	CcSEcCtD
Ivermectin—Anorexia—Betamethasone—multiple sclerosis	0.000215	0.00128	CcSEcCtD
Ivermectin—Urticaria—Prednisolone—multiple sclerosis	0.000215	0.00128	CcSEcCtD
Ivermectin—Fatigue—Triamcinolone—multiple sclerosis	0.000214	0.00128	CcSEcCtD
Ivermectin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000214	0.00359	CbGpPWpGaD
Ivermectin—Fatigue—Methylprednisolone—multiple sclerosis	0.000214	0.00128	CcSEcCtD
Ivermectin—Pain—Triamcinolone—multiple sclerosis	0.000212	0.00127	CcSEcCtD
Ivermectin—Hypotension—Betamethasone—multiple sclerosis	0.000211	0.00126	CcSEcCtD
Ivermectin—Hypotension—Dexamethasone—multiple sclerosis	0.000211	0.00126	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.00021	0.00352	CbGpPWpGaD
Ivermectin—Vomiting—Mitoxantrone—multiple sclerosis	0.000209	0.00125	CcSEcCtD
Ivermectin—Convulsion—Prednisone—multiple sclerosis	0.000208	0.00124	CcSEcCtD
Ivermectin—Rash—Mitoxantrone—multiple sclerosis	0.000208	0.00124	CcSEcCtD
Ivermectin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000207	0.00124	CcSEcCtD
Ivermectin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000207	0.00348	CbGpPWpGaD
Ivermectin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000207	0.00348	CbGpPWpGaD
Ivermectin—Chills—Methotrexate—multiple sclerosis	0.000207	0.00124	CcSEcCtD
Ivermectin—Headache—Mitoxantrone—multiple sclerosis	0.000206	0.00123	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000205	0.00123	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000205	0.00123	CcSEcCtD
Ivermectin—Myalgia—Prednisone—multiple sclerosis	0.000205	0.00122	CcSEcCtD
Ivermectin—Arthralgia—Prednisone—multiple sclerosis	0.000205	0.00122	CcSEcCtD
Ivermectin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000205	0.00122	CcSEcCtD
Ivermectin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000204	0.00122	CcSEcCtD
Ivermectin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000203	0.00121	CcSEcCtD
Ivermectin—Discomfort—Prednisone—multiple sclerosis	0.000202	0.00121	CcSEcCtD
Ivermectin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000199	0.00119	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000198	0.00332	CbGpPWpGaD
Ivermectin—Urticaria—Triamcinolone—multiple sclerosis	0.000197	0.00118	CcSEcCtD
Ivermectin—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	0.000197	0.00331	CbGpPWpGaD
Ivermectin—Urticaria—Methylprednisolone—multiple sclerosis	0.000197	0.00118	CcSEcCtD
Ivermectin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Ivermectin—Oedema—Prednisone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Ivermectin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Ivermectin—Decreased appetite—Betamethasone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Ivermectin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Ivermectin—Nausea—Mitoxantrone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Ivermectin—Back pain—Methotrexate—multiple sclerosis	0.000194	0.00116	CcSEcCtD
Ivermectin—Fatigue—Betamethasone—multiple sclerosis	0.000194	0.00116	CcSEcCtD
Ivermectin—Fatigue—Dexamethasone—multiple sclerosis	0.000194	0.00116	CcSEcCtD
Ivermectin—Pain—Betamethasone—multiple sclerosis	0.000193	0.00115	CcSEcCtD
Ivermectin—Pain—Dexamethasone—multiple sclerosis	0.000193	0.00115	CcSEcCtD
Ivermectin—Tachycardia—Prednisone—multiple sclerosis	0.000192	0.00114	CcSEcCtD
Ivermectin—Hyperhidrosis—Prednisone—multiple sclerosis	0.00019	0.00113	CcSEcCtD
Ivermectin—Anorexia—Prednisone—multiple sclerosis	0.000187	0.00112	CcSEcCtD
Ivermectin—NR1H4—Metabolism—SRM—multiple sclerosis	0.000187	0.00313	CbGpPWpGaD
Ivermectin—Anaemia—Methotrexate—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Ivermectin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Ivermectin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Ivermectin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000184	0.0011	CcSEcCtD
Ivermectin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000184	0.0011	CcSEcCtD
Ivermectin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000183	0.00109	CcSEcCtD
Ivermectin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000183	0.00109	CcSEcCtD
Ivermectin—NR1H4—Gene Expression—U2AF2—multiple sclerosis	0.000182	0.00305	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—HNRNPA1—multiple sclerosis	0.000182	0.00305	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000181	0.00304	CbGpPWpGaD
Ivermectin—Vertigo—Methotrexate—multiple sclerosis	0.000181	0.00108	CcSEcCtD
Ivermectin—Leukopenia—Methotrexate—multiple sclerosis	0.00018	0.00107	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.00018	0.00302	CbGpPWpGaD
Ivermectin—Urticaria—Betamethasone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Ivermectin—Urticaria—Dexamethasone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Ivermectin—Dizziness—Prednisolone—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Ivermectin—Asthenia—Triamcinolone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Ivermectin—Abdominal pain—Betamethasone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Ivermectin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Ivermectin—Body temperature increased—Betamethasone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Ivermectin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Ivermectin—Asthenia—Methylprednisolone—multiple sclerosis	0.000178	0.00106	CcSEcCtD
Ivermectin—Pruritus—Triamcinolone—multiple sclerosis	0.000176	0.00105	CcSEcCtD
Ivermectin—Cough—Methotrexate—multiple sclerosis	0.000175	0.00105	CcSEcCtD
Ivermectin—Pruritus—Methylprednisolone—multiple sclerosis	0.000175	0.00105	CcSEcCtD
Ivermectin—Convulsion—Methotrexate—multiple sclerosis	0.000174	0.00104	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—POMC—multiple sclerosis	0.000173	0.0029	CbGpPWpGaD
Ivermectin—Myalgia—Methotrexate—multiple sclerosis	0.000171	0.00102	CcSEcCtD
Ivermectin—Arthralgia—Methotrexate—multiple sclerosis	0.000171	0.00102	CcSEcCtD
Ivermectin—Chest pain—Methotrexate—multiple sclerosis	0.000171	0.00102	CcSEcCtD
Ivermectin—Decreased appetite—Prednisone—multiple sclerosis	0.000171	0.00102	CcSEcCtD
Ivermectin—Rash—Prednisolone—multiple sclerosis	0.00017	0.00102	CcSEcCtD
Ivermectin—Dermatitis—Prednisolone—multiple sclerosis	0.00017	0.00102	CcSEcCtD
Ivermectin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00017	0.00101	CcSEcCtD
Ivermectin—Fatigue—Prednisone—multiple sclerosis	0.000169	0.00101	CcSEcCtD
Ivermectin—Headache—Prednisolone—multiple sclerosis	0.000169	0.00101	CcSEcCtD
Ivermectin—Discomfort—Methotrexate—multiple sclerosis	0.000169	0.00101	CcSEcCtD
Ivermectin—Constipation—Prednisone—multiple sclerosis	0.000168	0.001	CcSEcCtD
Ivermectin—Confusional state—Methotrexate—multiple sclerosis	0.000165	0.000988	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—PGR—multiple sclerosis	0.000164	0.00276	CbGpPWpGaD
Ivermectin—Dizziness—Triamcinolone—multiple sclerosis	0.000164	0.000981	CcSEcCtD
Ivermectin—Dizziness—Methylprednisolone—multiple sclerosis	0.000164	0.000979	CcSEcCtD
Ivermectin—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000163	0.00274	CbGpPWpGaD
Ivermectin—Feeling abnormal—Prednisone—multiple sclerosis	0.000162	0.000966	CcSEcCtD
Ivermectin—Asthenia—Betamethasone—multiple sclerosis	0.000162	0.000966	CcSEcCtD
Ivermectin—Asthenia—Dexamethasone—multiple sclerosis	0.000162	0.000966	CcSEcCtD
Ivermectin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00016	0.000959	CcSEcCtD
Ivermectin—Nausea—Prednisolone—multiple sclerosis	0.00016	0.000959	CcSEcCtD
Ivermectin—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00016	0.00269	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00016	0.00268	CbGpPWpGaD
Ivermectin—Pruritus—Betamethasone—multiple sclerosis	0.000159	0.000953	CcSEcCtD
Ivermectin—Pruritus—Dexamethasone—multiple sclerosis	0.000159	0.000953	CcSEcCtD
Ivermectin—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	0.000159	0.00268	CbGpPWpGaD
Ivermectin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000159	0.000947	CcSEcCtD
Ivermectin—Vomiting—Triamcinolone—multiple sclerosis	0.000158	0.000944	CcSEcCtD
Ivermectin—Vomiting—Methylprednisolone—multiple sclerosis	0.000158	0.000941	CcSEcCtD
Ivermectin—Rash—Triamcinolone—multiple sclerosis	0.000157	0.000936	CcSEcCtD
Ivermectin—Dermatitis—Triamcinolone—multiple sclerosis	0.000156	0.000935	CcSEcCtD
Ivermectin—Anorexia—Methotrexate—multiple sclerosis	0.000156	0.000934	CcSEcCtD
Ivermectin—Rash—Methylprednisolone—multiple sclerosis	0.000156	0.000934	CcSEcCtD
Ivermectin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000156	0.000933	CcSEcCtD
Ivermectin—Urticaria—Prednisone—multiple sclerosis	0.000156	0.000932	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000156	0.00262	CbGpPWpGaD
Ivermectin—Headache—Triamcinolone—multiple sclerosis	0.000156	0.00093	CcSEcCtD
Ivermectin—Headache—Methylprednisolone—multiple sclerosis	0.000155	0.000928	CcSEcCtD
Ivermectin—Body temperature increased—Prednisone—multiple sclerosis	0.000155	0.000927	CcSEcCtD
Ivermectin—Abdominal pain—Prednisone—multiple sclerosis	0.000155	0.000927	CcSEcCtD
Ivermectin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000154	0.000921	CcSEcCtD
Ivermectin—Diarrhoea—Betamethasone—multiple sclerosis	0.000154	0.000921	CcSEcCtD
Ivermectin—Hypotension—Methotrexate—multiple sclerosis	0.000153	0.000916	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000151	0.00254	CbGpPWpGaD
Ivermectin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000149	0.000893	CcSEcCtD
Ivermectin—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000149	0.00251	CbGpPWpGaD
Ivermectin—Dizziness—Betamethasone—multiple sclerosis	0.000149	0.00089	CcSEcCtD
Ivermectin—Dizziness—Dexamethasone—multiple sclerosis	0.000149	0.00089	CcSEcCtD
Ivermectin—Nausea—Triamcinolone—multiple sclerosis	0.000148	0.000881	CcSEcCtD
Ivermectin—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000147	0.00248	CbGpPWpGaD
Ivermectin—Nausea—Methylprednisolone—multiple sclerosis	0.000147	0.000879	CcSEcCtD
Ivermectin—Dyspnoea—Methotrexate—multiple sclerosis	0.000146	0.000874	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000146	0.00245	CbGpPWpGaD
Ivermectin—Somnolence—Methotrexate—multiple sclerosis	0.000146	0.000871	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000145	0.00243	CbGpPWpGaD
Ivermectin—Hypersensitivity—Prednisone—multiple sclerosis	0.000145	0.000864	CcSEcCtD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000144	0.00242	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000144	0.00242	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—ZFP36L1—multiple sclerosis	0.000144	0.00241	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000144	0.00241	CbGpPWpGaD
Ivermectin—Vomiting—Dexamethasone—multiple sclerosis	0.000143	0.000856	CcSEcCtD
Ivermectin—Vomiting—Betamethasone—multiple sclerosis	0.000143	0.000856	CcSEcCtD
Ivermectin—Decreased appetite—Methotrexate—multiple sclerosis	0.000143	0.000852	CcSEcCtD
Ivermectin—Rash—Dexamethasone—multiple sclerosis	0.000142	0.000849	CcSEcCtD
Ivermectin—Rash—Betamethasone—multiple sclerosis	0.000142	0.000849	CcSEcCtD
Ivermectin—Dermatitis—Dexamethasone—multiple sclerosis	0.000142	0.000848	CcSEcCtD
Ivermectin—Dermatitis—Betamethasone—multiple sclerosis	0.000142	0.000848	CcSEcCtD
Ivermectin—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	0.000141	0.00238	CbGpPWpGaD
Ivermectin—Fatigue—Methotrexate—multiple sclerosis	0.000141	0.000845	CcSEcCtD
Ivermectin—Headache—Dexamethasone—multiple sclerosis	0.000141	0.000844	CcSEcCtD
Ivermectin—Headache—Betamethasone—multiple sclerosis	0.000141	0.000844	CcSEcCtD
Ivermectin—Asthenia—Prednisone—multiple sclerosis	0.000141	0.000841	CcSEcCtD
Ivermectin—Pain—Methotrexate—multiple sclerosis	0.00014	0.000838	CcSEcCtD
Ivermectin—Pruritus—Prednisone—multiple sclerosis	0.000139	0.00083	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000138	0.00232	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000136	0.00229	CbGpPWpGaD
Ivermectin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000135	0.000808	CcSEcCtD
Ivermectin—Diarrhoea—Prednisone—multiple sclerosis	0.000134	0.000802	CcSEcCtD
Ivermectin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000134	0.000801	CcSEcCtD
Ivermectin—Nausea—Betamethasone—multiple sclerosis	0.000134	0.0008	CcSEcCtD
Ivermectin—Nausea—Dexamethasone—multiple sclerosis	0.000134	0.0008	CcSEcCtD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000132	0.00221	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CYP24A1—multiple sclerosis	0.000131	0.00221	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CYP27B1—multiple sclerosis	0.000131	0.00221	CbGpPWpGaD
Ivermectin—Urticaria—Methotrexate—multiple sclerosis	0.00013	0.000779	CcSEcCtD
Ivermectin—Dizziness—Prednisone—multiple sclerosis	0.00013	0.000775	CcSEcCtD
Ivermectin—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00013	0.00218	CbGpPWpGaD
Ivermectin—Abdominal pain—Methotrexate—multiple sclerosis	0.00013	0.000775	CcSEcCtD
Ivermectin—Body temperature increased—Methotrexate—multiple sclerosis	0.00013	0.000775	CcSEcCtD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000128	0.00216	CbGpPWpGaD
Ivermectin—Vomiting—Prednisone—multiple sclerosis	0.000125	0.000746	CcSEcCtD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000124	0.00209	CbGpPWpGaD
Ivermectin—Rash—Prednisone—multiple sclerosis	0.000124	0.000739	CcSEcCtD
Ivermectin—Dermatitis—Prednisone—multiple sclerosis	0.000124	0.000739	CcSEcCtD
Ivermectin—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000123	0.00207	CbGpPWpGaD
Ivermectin—Headache—Prednisone—multiple sclerosis	0.000123	0.000735	CcSEcCtD
Ivermectin—GABRB3—Neuronal System—BCHE—multiple sclerosis	0.000123	0.00206	CbGpPWpGaD
Ivermectin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000121	0.000722	CcSEcCtD
Ivermectin—NR1H4—Metabolism—GPC5—multiple sclerosis	0.00012	0.00202	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.00012	0.00201	CbGpPWpGaD
Ivermectin—Asthenia—Methotrexate—multiple sclerosis	0.000118	0.000703	CcSEcCtD
Ivermectin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000117	0.00197	CbGpPWpGaD
Ivermectin—Nausea—Prednisone—multiple sclerosis	0.000117	0.000697	CcSEcCtD
Ivermectin—Pruritus—Methotrexate—multiple sclerosis	0.000116	0.000693	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—VDR—multiple sclerosis	0.000115	0.00193	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000113	0.0019	CbGpPWpGaD
Ivermectin—Diarrhoea—Methotrexate—multiple sclerosis	0.000112	0.000671	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000112	0.00188	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000112	0.00188	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—PABPC1—multiple sclerosis	0.000111	0.00187	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.00011	0.00185	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.00011	0.00185	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000109	0.00182	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000109	0.00182	CbGpPWpGaD
Ivermectin—Dizziness—Methotrexate—multiple sclerosis	0.000108	0.000648	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000108	0.00181	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000106	0.00178	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000106	0.00178	CbGpPWpGaD
Ivermectin—Vomiting—Methotrexate—multiple sclerosis	0.000104	0.000623	CcSEcCtD
Ivermectin—Rash—Methotrexate—multiple sclerosis	0.000103	0.000618	CcSEcCtD
Ivermectin—Dermatitis—Methotrexate—multiple sclerosis	0.000103	0.000617	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000103	0.00173	CbGpPWpGaD
Ivermectin—Headache—Methotrexate—multiple sclerosis	0.000103	0.000614	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000101	0.00169	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—RPL5—multiple sclerosis	0.000101	0.00169	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—RRM1—multiple sclerosis	9.96e-05	0.00167	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.83e-05	0.00165	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.76e-05	0.00164	CbGpPWpGaD
Ivermectin—Nausea—Methotrexate—multiple sclerosis	9.74e-05	0.000582	CcSEcCtD
Ivermectin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9.49e-05	0.00159	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.44e-05	0.00159	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.33e-05	0.00157	CbGpPWpGaD
Ivermectin—GLRA3—nervous system—multiple sclerosis	9.28e-05	0.182	CbGeAlD
Ivermectin—ABCC1—Metabolism—SRM—multiple sclerosis	9.11e-05	0.00153	CbGpPWpGaD
Ivermectin—GLRA3—central nervous system—multiple sclerosis	8.94e-05	0.175	CbGeAlD
Ivermectin—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.94e-05	0.0015	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.83e-05	0.00148	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.63e-05	0.00145	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.53e-05	0.00143	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—SRM—multiple sclerosis	8.02e-05	0.00135	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—PGR—multiple sclerosis	7.91e-05	0.00133	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.9e-05	0.00133	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.88e-05	0.00132	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.81e-05	0.00131	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.77e-05	0.00131	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.73e-05	0.0013	CbGpPWpGaD
Ivermectin—GLRA3—brain—multiple sclerosis	7.09e-05	0.139	CbGeAlD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.01e-05	0.00118	CbGpPWpGaD
Ivermectin—ABCC1—Disease—GPC5—multiple sclerosis	7.01e-05	0.00118	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.87e-05	0.00115	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.82e-05	0.00115	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	6.69e-05	0.00112	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.64e-05	0.00112	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CYP27B1—multiple sclerosis	6.42e-05	0.00108	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CYP24A1—multiple sclerosis	6.42e-05	0.00108	CbGpPWpGaD
Ivermectin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.34e-05	0.00106	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.27e-05	0.00105	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.23e-05	0.00105	CbGpPWpGaD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.22e-05	0.00104	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	6.08e-05	0.00102	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.05e-05	0.00102	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GPC5—multiple sclerosis	5.87e-05	0.000986	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.76e-05	0.000967	CbGpPWpGaD
Ivermectin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.75e-05	0.000965	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—BCHE—multiple sclerosis	5.72e-05	0.000961	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CYP24A1—multiple sclerosis	5.65e-05	0.000949	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CYP27B1—multiple sclerosis	5.65e-05	0.000949	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	5.62e-05	0.000943	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.55e-05	0.000933	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.53e-05	0.000929	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—VDR—multiple sclerosis	5.53e-05	0.000929	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.47e-05	0.000919	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.32e-05	0.000893	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GPC5—multiple sclerosis	5.17e-05	0.000868	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—RRM1—multiple sclerosis	4.86e-05	0.000817	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.69e-05	0.000787	CbGpPWpGaD
Ivermectin—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.68e-05	0.000785	CbGpPWpGaD
Ivermectin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.66e-05	0.000782	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—MYC—multiple sclerosis	4.57e-05	0.000767	CbGpPWpGaD
Ivermectin—ABCC1—Disease—RPL5—multiple sclerosis	4.56e-05	0.000766	CbGpPWpGaD
Ivermectin—ABCC1—Disease—SLC11A1—multiple sclerosis	4.37e-05	0.000733	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—SRM—multiple sclerosis	4.33e-05	0.000728	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.32e-05	0.000725	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—RRM1—multiple sclerosis	4.28e-05	0.000719	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.2e-05	0.000706	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.03e-05	0.000677	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.77e-05	0.000634	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.71e-05	0.000624	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—MAPK1—multiple sclerosis	3.58e-05	0.000602	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CD28—multiple sclerosis	3.49e-05	0.000586	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—APOE—multiple sclerosis	3.44e-05	0.000578	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.24e-05	0.000545	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.11e-05	0.000522	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.05e-05	0.000513	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.05e-05	0.000513	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—POMC—multiple sclerosis	2.96e-05	0.000497	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.96e-05	0.000496	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.84e-05	0.000478	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.81e-05	0.000472	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—BCHE—multiple sclerosis	2.79e-05	0.000469	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GPC5—multiple sclerosis	2.79e-05	0.000469	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ALB—multiple sclerosis	2.7e-05	0.000453	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—SRM—multiple sclerosis	2.67e-05	0.000448	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CD86—multiple sclerosis	2.49e-05	0.000418	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.47e-05	0.000416	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.47e-05	0.000415	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—BCHE—multiple sclerosis	2.46e-05	0.000413	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—RRM1—multiple sclerosis	2.31e-05	0.000389	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CCR5—multiple sclerosis	2.21e-05	0.00037	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—MYC—multiple sclerosis	2.2e-05	0.000369	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HLA-A—multiple sclerosis	2.15e-05	0.000361	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.14e-05	0.000359	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.13e-05	0.000358	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.09e-05	0.000351	CbGpPWpGaD
Ivermectin—ABCC1—Disease—APOE—multiple sclerosis	2.01e-05	0.000337	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.99e-05	0.000334	CbGpPWpGaD
Ivermectin—GABRB3—medulla oblongata—multiple sclerosis	1.98e-05	0.0389	CbGeAlD
Ivermectin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.000316	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.000316	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CD80—multiple sclerosis	1.81e-05	0.000305	CbGpPWpGaD
Ivermectin—GABRB3—midbrain—multiple sclerosis	1.81e-05	0.0355	CbGeAlD
Ivermectin—GABRB3—spinal cord—multiple sclerosis	1.77e-05	0.0347	CbGeAlD
Ivermectin—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.000289	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—APOE—multiple sclerosis	1.68e-05	0.000282	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TYK2—multiple sclerosis	1.53e-05	0.000257	CbGpPWpGaD
Ivermectin—GABRB3—nervous system—multiple sclerosis	1.49e-05	0.0292	CbGeAlD
Ivermectin—ABCG2—Metabolism—APOE—multiple sclerosis	1.48e-05	0.000248	CbGpPWpGaD
Ivermectin—ABCG2—medulla oblongata—multiple sclerosis	1.46e-05	0.0286	CbGeAlD
Ivermectin—ABCC1—Metabolism—POMC—multiple sclerosis	1.44e-05	0.000243	CbGpPWpGaD
Ivermectin—GABRB3—central nervous system—multiple sclerosis	1.44e-05	0.0281	CbGeAlD
Ivermectin—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.000239	CbGpPWpGaD
Ivermectin—GABRB3—cerebellum—multiple sclerosis	1.4e-05	0.0275	CbGeAlD
Ivermectin—ABCC1—Disease—CD4—multiple sclerosis	1.39e-05	0.000233	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.34e-05	0.000225	CbGpPWpGaD
Ivermectin—ABCG2—midbrain—multiple sclerosis	1.33e-05	0.0261	CbGeAlD
Ivermectin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000223	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ALB—multiple sclerosis	1.32e-05	0.000221	CbGpPWpGaD
Ivermectin—ABCG2—spinal cord—multiple sclerosis	1.3e-05	0.0255	CbGeAlD
Ivermectin—ABCG2—Metabolism—POMC—multiple sclerosis	1.27e-05	0.000213	CbGpPWpGaD
Ivermectin—ABCC1—cerebellum—multiple sclerosis	1.25e-05	0.0244	CbGeAlD
Ivermectin—ABCG2—Metabolism—ALB—multiple sclerosis	1.16e-05	0.000195	CbGpPWpGaD
Ivermectin—GABRB3—brain—multiple sclerosis	1.14e-05	0.0223	CbGeAlD
Ivermectin—ABCC1—Disease—STAT3—multiple sclerosis	1.07e-05	0.00018	CbGpPWpGaD
Ivermectin—ABCG2—cerebellum—multiple sclerosis	1.03e-05	0.0202	CbGeAlD
Ivermectin—ABCC1—brain—multiple sclerosis	1.01e-05	0.0198	CbGeAlD
Ivermectin—ABCC1—Disease—MYC—multiple sclerosis	9.97e-06	0.000167	CbGpPWpGaD
Ivermectin—ABCB1—retina—multiple sclerosis	9.95e-06	0.0195	CbGeAlD
Ivermectin—ABCC1—Disease—TGFB1—multiple sclerosis	9.94e-06	0.000167	CbGpPWpGaD
Ivermectin—ABCC1—Disease—MAPK1—multiple sclerosis	9.75e-06	0.000164	CbGpPWpGaD
Ivermectin—ABCG2—brain—multiple sclerosis	8.37e-06	0.0164	CbGeAlD
Ivermectin—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.19e-06	0.000138	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—APOE—multiple sclerosis	8e-06	0.000134	CbGpPWpGaD
Ivermectin—CYP3A4—nervous system—multiple sclerosis	7.63e-06	0.015	CbGeAlD
Ivermectin—ABCC1—Disease—IL6—multiple sclerosis	7.49e-06	0.000126	CbGpPWpGaD
Ivermectin—CYP3A4—central nervous system—multiple sclerosis	7.35e-06	0.0144	CbGeAlD
Ivermectin—ABCB1—medulla oblongata—multiple sclerosis	7.19e-06	0.0141	CbGeAlD
Ivermectin—ABCB1—Metabolism—POMC—multiple sclerosis	6.87e-06	0.000115	CbGpPWpGaD
Ivermectin—ABCB1—midbrain—multiple sclerosis	6.57e-06	0.0129	CbGeAlD
Ivermectin—ABCB1—spinal cord—multiple sclerosis	6.41e-06	0.0126	CbGeAlD
Ivermectin—ABCB1—Metabolism—ALB—multiple sclerosis	6.26e-06	0.000105	CbGpPWpGaD
Ivermectin—ABCB1—nervous system—multiple sclerosis	5.4e-06	0.0106	CbGeAlD
Ivermectin—ABCB1—central nervous system—multiple sclerosis	5.2e-06	0.0102	CbGeAlD
Ivermectin—ABCB1—cerebellum—multiple sclerosis	5.08e-06	0.00996	CbGeAlD
Ivermectin—CYP3A4—Metabolism—APOE—multiple sclerosis	4.93e-06	8.27e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—POMC—multiple sclerosis	4.23e-06	7.11e-05	CbGpPWpGaD
Ivermectin—ABCB1—brain—multiple sclerosis	4.13e-06	0.00809	CbGeAlD
Ivermectin—CYP3A4—Metabolism—ALB—multiple sclerosis	3.86e-06	6.48e-05	CbGpPWpGaD
